Zhejiang Dayang Biotech Group Co (003017) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.001x

Based on the latest financial reports, Zhejiang Dayang Biotech Group Co (003017) has a cash flow conversion efficiency ratio of 0.001x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥638.25K ≈ $93.40K USD) by net assets (CN¥1.10 Billion ≈ $161.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Zhejiang Dayang Biotech Group Co for the company's overall valuation and market capitalisation.

Zhejiang Dayang Biotech Group Co - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhejiang Dayang Biotech Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Dayang Biotech Group Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Dayang Biotech Group Co ranked by their cash flow conversion efficiency. Explore 003017 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Jiusheng Electric Co. LTD SHE:301082	N/A
Fujian Yuanxiang New Materials Co. Ltd. A SHE:301300	N/A
Orchestra BioMed Holdings Inc. NASDAQ:OBIO	-0.657x
Wuxi Xinan Technology Co. Ltd. A SHE:301170	N/A
Ningbo Water Meter Co Ltd SHG:603700	0.020x
Jiangsu Feiliks Intl Logistics SHE:300240	-0.006x
ZCCM Investments Holdings Plc PA:MLZAM	-0.002x
Jiangsu Daybright Intelligent Electric Co Ltd SHE:300670	0.030x

Annual Cash Flow Conversion Efficiency for Zhejiang Dayang Biotech Group Co (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Dayang Biotech Group Co from 2013 to 2025. View latest Zhejiang Dayang Biotech Group Co stock price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.14 Billion ≈ $166.34 Million	CN¥160.11 Million ≈ $23.43 Million	0.141x	+124.09%
2024-12-31	CN¥1.05 Billion ≈ $154.11 Million	CN¥66.19 Million ≈ $9.69 Million	0.063x	-65.26%
2023-12-31	CN¥1.01 Billion ≈ $147.53 Million	CN¥182.42 Million ≈ $26.69 Million	0.181x	+93.97%
2022-12-31	CN¥985.05 Million ≈ $144.14 Million	CN¥91.89 Million ≈ $13.45 Million	0.093x	+362.87%
2021-12-31	CN¥990.71 Million ≈ $144.97 Million	CN¥-35.16 Million ≈ $-5.14 Million	-0.035x	-130.23%
2020-12-31	CN¥958.13 Million ≈ $140.20 Million	CN¥112.49 Million ≈ $16.46 Million	0.117x	-48.29%
2019-12-31	CN¥498.09 Million ≈ $72.89 Million	CN¥113.09 Million ≈ $16.55 Million	0.227x	+158.02%
2018-12-31	CN¥440.62 Million ≈ $64.48 Million	CN¥38.77 Million ≈ $5.67 Million	0.088x	-38.90%
2017-12-31	CN¥337.71 Million ≈ $49.42 Million	CN¥48.64 Million ≈ $7.12 Million	0.144x	-60.97%
2016-12-31	CN¥229.35 Million ≈ $33.56 Million	CN¥84.63 Million ≈ $12.38 Million	0.369x	+58.13%
2015-12-31	CN¥209.76 Million ≈ $30.70 Million	CN¥48.95 Million ≈ $7.16 Million	0.233x	-20.42%
2014-12-31	CN¥196.87 Million ≈ $28.81 Million	CN¥57.73 Million ≈ $8.45 Million	0.293x	-40.03%
2013-12-31	CN¥187.42 Million ≈ $27.43 Million	CN¥91.64 Million ≈ $13.41 Million	0.489x	--

About Zhejiang Dayang Biotech Group Co

SHE:003017 China Chemicals

Market Cap

$327.45 Million

CN¥2.24 Billion CNY

Market Cap Rank

#14519 Global

#4341 in China

Share Price

CN¥22.20

Change (1 day)

+2.21%

52-Week Range

CN¥19.40 - CN¥35.05

All Time High

CN¥39.37